6/7/2022

Norepinephrine Bitartrate Injection

Products Affected - Description

- Levophed injection, Pfizer, 1 mg/mL, 4 mL ampule, 10 count, NDC 00409-1143-04 - discontinued
- Norepinephrine injection, Teva, 1 mg/mL, 4 mL vial, 10 count, NDC 00703-1153-03 - discontinued

Reason for the Shortage

- Amneal has norepinephrine injection available.
- Baxter has norepinephrine injection available.
- Hikma has norepinephrine injection available.
- Mylan Institutional has norepinephrine injection available.
- Pfizer has Levophed vials available.
- Sandoz has norepinephrine injection available.
- Teva discontinued norepinephrine in April 2022.

Available Products

- Levophed injection, Pfizer, 1 mg/mL, 4 mL vial, 10 count, NDC 00409-3375-04
- Norepinephrine injection, Amneal, 1 mg/mL, 4 mL vial, 10 count, NDC 70121-1576-07
- Norepinephrine injection, Baxter, 1 mg/mL, 4 mL ampule, 10 count, NDC 36000-0162-10
- Norepinephrine injection, Hikma, 1 mg/mL, 4 mL vial, 10 count, NDC 00143-9318-10
- Norepinephrine injection, Mylan Institutional, 1 mg/mL, 4 mL vial, 10 count, NDC 67457-0852-04
- Norepinephrine injection, Sandoz, 1 mg/mL, 4 mL vial, 10 count, NDC 00781-3755-95

Estimated Resupply Dates

- All marketed presentations are available.

Updated

Updated June 7, 2022 by Michelle Wheeler, PharmD, Drug Information Specialist. Created February 22, 2017 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2022, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.